These results show Mcl-1′s ability to regulate ROS production under CIS conditions depends on residues in the loop domain (and not its canonical C-terminal anti-apoptotic domain) also known to regulate its anti-CIS function [10]. The gene discussed is MCL1; the disease is in situ carcinoma.